Zobrazeno 1 - 10
of 295
pro vyhledávání: '"Olaf H Klungel"'
Autor:
Aukje K Mantel-Teeuwisse, Rick A Vreman, Olaf H Klungel, Junfeng Wang, Li Jiu, Michiel Hartog, Wim G Goettsch
Publikováno v:
BMJ Open, Vol 14, Iss 2 (2024)
Objectives We aimed to identify existing appraisal tools for non-randomised studies of interventions (NRSIs) and to compare the criteria that the tools provide at the quality-item level.Design Literature review through three approaches: systematic se
Externí odkaz:
https://doaj.org/article/eca10fb6c00541ad97d8d3bec20823d7
Autor:
Hilda J I de Jong, Jan Willem Cohen Tervaert, Arief Lalmohamed, Frank de Vries, Rob J Vandebriel, Henk van Loveren, Olaf H Klungel, Tjeerd P van Staa
Publikováno v:
PLoS ONE, Vol 13, Iss 2, p e0193297 (2018)
We examined the association between statin use and the risk of rheumatoid arthritis (RA), with special focus on describing the patterns of risks of RA during statin exposure in a large population-based cohort in the United Kingdom. In the Clinical Pr
Externí odkaz:
https://doaj.org/article/46b6bf0956e64b249549f86619e413d5
Autor:
Marietta Rottenkolber, Eef Voogd, Liset van Dijk, Paola Primatesta, Claudia Becker, Raymond Schlienger, Mark C H de Groot, Yolanda Alvarez, Julie Durand, Jim Slattery, Ana Afonso, Gema Requena, Miguel Gil, Arturo Alvarez, Ulrik Hesse, Roman Gerlach, Joerg Hasford, Rainald Fischer, Olaf H Klungel, Sven Schmiedl
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0117628 (2015)
BACKGROUND:Inhaled, long-acting beta-2-adrenoceptor agonists (LABA) have well-established roles in asthma and/or COPD treatment. Drug utilisation patterns for LABA have been described, but few studies have directly compared LABA use in different coun
Externí odkaz:
https://doaj.org/article/1019e932aac84dc198def52afaaf1eb4
Autor:
Sven Schmiedl, Rainald Fischer, Luisa Ibáñez, Joan Fortuny, Olaf H Klungel, Robert Reynolds, Roman Gerlach, Martin Tauscher, Petra Thürmann, Joerg Hasford, Marietta Rottenkolber
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e105110 (2014)
Respiratory drugs are widely used in children to treat labeled and non-labeled indications but only some data are available quantifying comprehensively off-label usage. Thus, we aim to analyse drug utilisation and off-label prescribing of respiratory
Externí odkaz:
https://doaj.org/article/56bab6ea03154be7941ca58388dc0fe8
Autor:
Grace Wangge, Michelle Putzeist, Mirjam J Knol, Olaf H Klungel, Christine C Gispen-De Wied, Antonius de Boer, Arno W Hoes, Hubert G Leufkens, Aukje K Mantel-Teeuwisse
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e74818 (2013)
The active-controlled trial with a non-inferiority design has gained popularity in recent years. However, non-inferiority trials present some methodological challenges, especially in determining the non-inferiority margin. Regulatory guidelines provi
Externí odkaz:
https://doaj.org/article/41f4581e6bd243c9827bd962f70ffa8c
Autor:
Hilda J I De Jong, Jan G M C Damoiseaux, Rob J Vandebriel, Patrick C Souverein, Eric R Gremmer, Mia Wolfs, Olaf H Klungel, Henk Van Loveren, Jan Willem Cohen Tervaert, W M Monique Verschuren
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e77587 (2013)
It has been suggested that statins can both stimulate and suppress the immune system, and thereby, may influence autoimmune diseases. Therefore, we studied effects of statins on innate and adaptive immunity, and self-tolerance by measuring serologica
Externí odkaz:
https://doaj.org/article/124b362cf8ab47bdb8cd1697b02bc1ab
Autor:
Hilda J I de Jong, Siti R F Saldi, Olaf H Klungel, Rob J Vandebriel, Patrick C Souverein, Ronald H B Meyboom, J L M Anneke Passier, Henk van Loveren, Jan Willem Cohen Tervaert
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e41289 (2012)
OBJECTIVE: To assess whether there is an association between statin use and the occurrence of polymyalgia rheumatic (PMR) in the spontaneous reporting database of the World Health Organisation (WHO). METHODS: We conducted a case/non-case study based
Externí odkaz:
https://doaj.org/article/c49df982f29344419d1fbff690241cf8
Autor:
Jana V van Vliet-Ostaptchouk, Timon W van Haeften, Gijs W D Landman, Erwin Reiling, Nanne Kleefstra, Henk J G Bilo, Olaf H Klungel, Anthonius de Boer, Cleo C van Diemen, Cisca Wijmenga, H Marike Boezen, Jacqueline M Dekker, Esther van 't Riet, Giel Nijpels, Laura M C Welschen, Hata Zavrelova, Elinda J Bruin, Clara C Elbers, Florianne Bauer, N Charlotte Onland-Moret, Yvonne T van der Schouw, Diederick E Grobbee, Annemieke M W Spijkerman, Daphne L van der A, Annemarie M Simonis-Bik, Elisabeth M W Eekhoff, Michaela Diamant, Mark H H Kramer, Dorret I Boomsma, Eco J de Geus, Gonneke Willemsen, P Eline Slagboom, Marten H Hofker, Leen M 't Hart
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e32148 (2012)
BACKGROUND:Genome-wide association studies in Japanese populations recently identified common variants in the KCNQ1 gene to be associated with type 2 diabetes. We examined the association of these variants within KCNQ1 with type 2 diabetes in a Dutch
Externí odkaz:
https://doaj.org/article/9ad5fb82e74d460cbe4a3a4b682811c2
Publikováno v:
PLoS ONE, Vol 5, Iss 10, p e13550 (2010)
BACKGROUND: A non-inferiority (NI) trial is intended to show that the effect of a new treatment is not worse than the comparator. We conducted a review to identify how NI trials were conducted and reported, and whether the standard requirements from
Externí odkaz:
https://doaj.org/article/869e1b8d444f4c609264e085fa2ee0be
Autor:
Nicholas B. Hunt, Romin Pajouheshnia, Allan Salih, Sander van Doorn, Patrick C. Souverein, Marloes T. Bazelier, Olaf H. Klungel, Helga Gardarsdottir
Publikováno v:
British Journal of Clinical Pharmacology.
Aims: Low-dose rivaroxaban has been indicated for the management of atherosclerotic cardiovascular disease (ASCVD) after recent (2019-2020) updates to European guidelines. We aimed to describe prescription trends of low-dose rivaroxaban in ASCVD pati